Superworth

Airsculpt Technologies EV/EBIT AIRS

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2023.

Today, Oct 23, 2026
n/m
an operating loss
Last meaningful
74.4×
Mar 2025
Peer median
7.8×

Airsculpt Technologies has no meaningful EV/EBIT today: it made an operating loss of $12.6M over the last twelve months.

It was last meaningful in Mar 2025, at 74.4×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
202574.4×74.4×117×
2024110×14.2×246×
2023233×164×233×

Against its peers

Companies in Healthcare nearest Airsculpt Technologies' size, closest first, today.

CompanyEV/EBIT
AIRSAirsculpt Technologiesn/m
ICCCImmucell14.2×
KEQUKewaunee Scientific7.2×
LFVNLifevantage9.6×
SPROSpero Therapeutics2.1×
APTAlpha Pro Tech8.2×
ATNMActinium Pharmaceuticals1.2×
NEPHNephros20.5×
PDEXPro DEX16.0×
PLXProtalix BioTherapeutics7.5×
NATRNatures Sunshine Products5.2×
Peer median7.8×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Airsculpt Technologies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.